PCG
VOR icon

Private Capital Group’s Vor Biopharma VOR Stock Holding History

Private Capital Group’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2
Closed -$1K – 2185
2021
Q1 		$1K Buy
+2
New +$1.69K ﹤0.01% 1948

Other funds holding VOR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
JJIJ
Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Private Capital Group's VOR Position: Q2 2021 in Review

Private Capital Group sold out of Vor Biopharma (VOR) in Q2 2021, closing a stake of 2 shares — an estimated $1K sold.

Private Capital Group first reported a position in VOR in Q1 2021 and held it in 1 quarter. The position peaked at $1K in Q1 2021. 51 funds tracked by Wall St. Rank hold VOR as of Q2 2021.

  • Private Capital Group reported no remaining Vor Biopharma position as of Q2 2021 after selling out during the quarter.
  • Private Capital Group sold 2 Vor Biopharma shares in Q2 2021, an estimated $1K.
  • Private Capital Group first reported a position in Vor Biopharma in Q1 2021 and held it in 1 quarter.
  • Private Capital Group's Vor Biopharma position peaked at $1K in Q1 2021.
  • 51 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2021.

Based on Private Capital Group's 13F filing for Q2 2021, filed 26 Jul 2021.